# Rescue of Steroidogenic Capacity in Adrenocortical Failure Study (RADS)

> **NCT00753597** · PHASE4 · COMPLETED · sponsor: **Newcastle University** · enrollment: 6 (actual)

## Conditions studied

- Autoimmune Adrenocortical Failure

## Interventions

- **DRUG:** Solu-medrone, Mabthera

## Key facts

- **NCT ID:** NCT00753597
- **Lead sponsor:** Newcastle University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2013-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00753597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00753597, "Rescue of Steroidogenic Capacity in Adrenocortical Failure Study (RADS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00753597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*